1. Volume 5, Issue 7, Pages 572-575 (July 2019)
Nivolumab in non–small cell lung cancer: A novel case of an erythema annulare centrifugum–like eruption 
Polytimi Sidiropoulou, MD, Themis Sgontzou, MD, Ioanna Kostara, MD, Dimitrios Sgouros, MD, Barbara Theologi, MD, Eftychia Zouridaki, MD, PhD, Georgios Kontochristopoulos, MD, PhD, Dimitris Rigopoulos, MD, PhD, Alexander J Stratigos, MD, PhD 
JAAD Case Reports 
Volume 5, Issue 7, Pages (July 2019)
DOI: /j.jdcr
Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions

2. Fig 1
EAC clinical features at 4 months after nivolumab discontinuation. A, Pruritic arcuate, figurate and polycyclic erythematous plaques involving the back. B, The lesions display slightly raised borders with an inner rim of fine scale behind the advancing edges.
JAAD Case Reports 2019 5, DOI: ( /j.jdcr )
Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions

3. Fig 2
A and B, Skin biopsy shows focal basal vacuolar degeneration into the epidermis and subepidermal perivascular lymphocytic infiltrate in the upper and mid dermis. (Hematoxylin-eosin stain.) A high-resolution version of this image for use with the Virtual Microscope is available as eSlide: VM05504.
JAAD Case Reports 2019 5, DOI: ( /j.jdcr )
Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions